logo-loader
viewAmryt Pharma PLC

Amryt Pharma's Joe Wiley delighted as company begins trading on NASDAQ

Amryt Pharma PLC's (LON:AMYT) Joe Wiley speaks to Proactive London's Andrew Scott as the company began trading on NASDAQ.

Wiley says he's delighted and it's a big day for the company which they've been building towards for some time.

He's hoping the move will 'enhance the value of its equity on both sides of the Atlantic' as well as broaden its analyst coverage.

Quick facts: Amryt Pharma PLC

Price: 182.5 GBX

AIM:AMYT
Market: AIM
Market Cap: £289.26 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Amryt Pharma PLC named herein, including the promotion by the Company of Amryt Pharma PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Amryt Pharma releases Q-2 financials that show strong revenue growth as...

Amryt Pharma (Nasdaq: AMYT) CEO Dr Joe Wiley joined Steve Darling from Proactive with news the company saw a nice increase in revenue as they released their Q-2 numbers. Dr Wiley talked about some of the numbers and what was driving that revenue. Wiley also told Proactive the company has, for...

6 days, 7 hours ago

2 min read